|Platelet activation is associated with myocardial infarction in patients with pneumonia|
R Cangemi, M Casciaro, E Rossi, C Calvieri, T Bucci, CM Calabrese, ...
Journal of the American College of Cardiology 64 (18), 1917-1925, 2014
|Evaluation of the HAS-BLED, ATRIA, and ORBIT bleeding risk scores in patients with atrial fibrillation taking warfarin|
K Senoo, M Proietti, DA Lane, GYH Lip
The American journal of medicine 129 (6), 600-607, 2016
|Adherence to oral anticoagulant therapy in patients with atrial fibrillation|
V Raparelli, M Proietti, R Cangemi, GYH Lip, DA Lane, S Basili
Thrombosis and haemostasis 117 (02), 209-218, 2017
|Asymptomatic versus symptomatic atrial fibrillation: a systematic review of age/gender differences and cardiovascular outcomes|
Q Xiong, M Proietti, K Senoo, GYH Lip
International journal of cardiology 191, 172-177, 2015
|Atrial fibrillation and thromboembolism in patients with chronic kidney disease|
YC Lau, M Proietti, E Guiducci, AD Blann, GYH Lip
Journal of the American College of Cardiology 68 (13), 1452-1464, 2016
|Simple decision-making between a vitamin K antagonist and a non-vitamin K antagonist oral anticoagulant: using the SAMe-TT2R2 score|
M Proietti, GYH Lip
European Heart Journal-Cardiovascular Pharmacotherapy 1 (3), 150-152, 2015
|Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: implications for risk and therapy|
F Violi, G Daví, W Hiatt, GYH Lip, GR Corazza, F Perticone, M Proietti, ...
Journal of the American College of Cardiology 62 (23), 2255-2256, 2013
|Major bleeding in patients with non-valvular atrial fibrillation: impact of time in therapeutic range on contemporary bleeding risk scores|
M Proietti, K Senoo, DA Lane, GYH Lip
Scientific reports 6, 24376, 2016
|Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study|
M Proietti, A Nobili, V Raparelli, L Napoleone, PM Mannucci, GYH Lip
Clinical Research in Cardiology 105 (11), 912-920, 2016
|Platelet isoprostane overproduction in diabetic patients treated with aspirin|
R Cangemi, P Pignatelli, R Carnevale, C Nigro, M Proietti, F Angelico, ...
Diabetes 61 (6), 1626-1632, 2012
|Polypharmacy and major adverse events in atrial fibrillation: observations from the AFFIRM trial|
M Proietti, V Raparelli, B Olshansky, GYH Lip
Clinical Research in Cardiology 105 (5), 412-420, 2016
|A population screening programme for atrial fibrillation: a report from the Belgian Heart Rhythm Week screening programme|
M Proietti, GH Mairesse, P Goethals, C Scavee, J Vijgen, I Blankoff, ...
Ep Europace 18 (12), 1779-1786, 2016
|Elderly obese women display the greatest improvement in stair climbing performance after a 3-week body mass reduction program|
A Sartorio, CL Lafortuna, F Agosti, M Proietti, NA Maffiuletti
International journal of obesity 28 (9), 1097, 2004
|VEGF-A gene promoter polymorphisms and microvascular complications in patients with essential hypertension|
R Palmirotta, P Ferroni, G Ludovici, F Martini, A Savonarola, ...
Clinical biochemistry 43 (13-14), 1090-1095, 2010
|Frequency of left ventricular hypertrophy in non-valvular atrial fibrillation|
M Proietti, AM Marra, EJ Tassone, S De Vuono, S Corrao, P Gobbi, ...
The American journal of cardiology 116 (6), 877-882, 2015
|‘Real-world’atrial fibrillation management in Europe: observations from the 2-year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry …|
M Proietti, C Laroche, G Opolski, AP Maggioni, G Boriani, GYH Lip, ...
Europace 19 (5), 722-733, 2016
|Chronic kidney disease, time in therapeutic range and adverse clinical outcomes in anticoagulated patients with non-valvular atrial fibrillation: observations from the SPORTIF …|
M Proietti, DA Lane, GYH Lip
EBioMedicine 8, 309-316, 2016
|Relationship between carotid intima-media thickness and non valvular atrial fibrillation type|
M Proietti, C Calvieri, L Malatino, S Signorelli, GR Corazza, F Perticone, ...
Atherosclerosis 238 (2), 350-355, 2015
|Real-world use of apixaban for stroke prevention in atrial fibrillation: a systematic review and meta-analysis|
M Proietti, I Romanazzi, GF Romiti, A Farcomeni, GYH Lip
Stroke 49 (1), 98-106, 2018
|Is There an Obesity Paradox for Outcomes in Atrial Fibrillation? A Systematic Review and Meta-Analysis of Non–Vitamin K Antagonist Oral Anticoagulant Trials|
M Proietti, E Guiducci, P Cheli, GYH Lip
Stroke 48 (4), 857-866, 2017